We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$163M
AUM Growth
+$15.4M
Cap. Flow
+$9.59M
Cap. Flow %
5.87%
Top 10 Hldgs %
57.69%
Holding
80
New
15
Increased
17
Reduced
17
Closed
15

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.45M
2
BIIB icon
Biogen
BIIB
+$1.36M
3
VIR icon
Vir Biotechnology
VIR
+$972K
4
BABA icon
Alibaba
BABA
+$611K
5
PRTA icon
Prothena Corp
PRTA
+$536K

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$3.37M
2
TPB icon
Turning Point Brands
TPB
+$1.83M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$1.82M
4
NFLX icon
Netflix
NFLX
+$1M
5
PYPL icon
PayPal
PYPL
+$499K

Sector Composition

Rank Sector Weight
1 Healthcare 39.59%
2 Technology 13.98%
3 Communication Services 7.11%
4 Consumer Discretionary 3.08%
5 Energy 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSM icon
76
CALL
TSMC
TSM
$2.1T
– –
-7,500
Closed -$559K
VOO icon
77
PUT
Vanguard S&P 500 ETF
VOO
$979B
– –
-5,000
Closed -$1.76M
XBI icon
78
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-3,500
Closed -$291K
XLE icon
79
PUT
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
– –
-5,000
Closed -$219K
1 2 3
4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, DCF Advisers held 80 positions worth $163M, up 10% from $148M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

DCF Advisers deployed $9.59M of net new capital in Q1 2023, opening 15 new positions and adding to 17 existing holdings. Its largest new stake was Amgen: 10,000 shares worth $2.42M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Bank of America, an estimated $3.37M trimmed.

  • DCF Advisers's largest Q1 2023 buy was Amgen: 10,000 shares worth $2.42M.
  • DCF Advisers added most to Vir Biotechnology in Q1 2023, an estimated $972K increase.
  • DCF Advisers's biggest Q1 2023 reduction was Bank of America, cutting an estimated $3.37M.
  • DCF Advisers fully exited Turning Point Brands in Q1 2023, selling an estimated $1.83M.
  • DCF Advisers's ten largest holdings make up 58% of its $163M portfolio in Q1 2023.
  • DCF Advisers opened 15 new positions and closed 15 in Q1 2023.
  • DCF Advisers's portfolio value rose 10% quarter-over-quarter to $163M.

Based on DCF Advisers's 13F filing for Q1 2023, filed 15 May 2023.